These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 21311333)

  • 1. Contemporary role of radiation therapy in the adjuvant or salvage setting following radical prostatectomy.
    Cozzarini C; Di Muzio N
    Curr Opin Urol; 2011 May; 21(3):206-10. PubMed ID: 21311333
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Radiation therapy after radical prostatectomy: a review of the issues and options.
    Valicenti RK; Gomella LG; Perez CA
    Semin Radiat Oncol; 2003 Apr; 13(2):130-40. PubMed ID: 12728442
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Adjuvant and salvage radiotherapy after radical prostatectomy].
    Milecki P; Kwias Z; Skowronek J; Stachowski T
    Pol Merkur Lekarski; 2004 May; 16(95):495-9. PubMed ID: 15518437
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Salvage radiotherapy in rising PSA after radical prostatectomy].
    Carrie C; Pommier P
    Cancer Radiother; 2007 Nov; 11(6-7):370-2. PubMed ID: 17869564
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adjuvant and salvage treatment options for patients with high-risk prostate cancer treated with radical prostatectomy.
    Kibel AS; Nelson JB
    Prostate Cancer Prostatic Dis; 2007; 10(2):119-26. PubMed ID: 17310261
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy and tolerance of salvage radiotherapy after radical prostatectomy, with emphasis on high-risk patients suited for adjuvant radiotherapy.
    Cremers RG; van Lin EN; Gerrits WL; van Tol-Geerdink JJ; Kiemeney LA; Vergunst H; Smans AJ; Kaanders JH; Alfred Witjes J
    Radiother Oncol; 2010 Dec; 97(3):467-73. PubMed ID: 20817287
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term results of adjuvant hormonal therapy plus radiotherapy following radical prostatectomy for patients with pT3N0 or pT3N1 prostate cancer.
    Miyake H; Sakai I; Harada K; Hara I; Eto H
    Int J Urol; 2004 Jun; 11(6):397-401. PubMed ID: 15157209
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Contemporary treatment of high-risk localized prostate cancer.
    Tareen B; Kimmel J; Huang WC
    Expert Rev Anticancer Ther; 2010 Jul; 10(7):1069-76. PubMed ID: 20645696
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Salvage radiotherapy for biochemical and clinical failures following radical prostatectomy.
    Do T; Parker RG; Do C; Tran L; Do L; Dolkar D
    Cancer J Sci Am; 1998; 4(5):324-30. PubMed ID: 9815297
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of radiation therapy in prostate cancer after radical prostatectomy: when and why?
    Catton C
    Curr Opin Support Palliat Care; 2010 Sep; 4(3):135-40. PubMed ID: 20613536
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Radiotherapy after prostatectomy: is the evidence for dose escalation out there?
    King CR; Kapp DS
    Int J Radiat Oncol Biol Phys; 2008 Jun; 71(2):346-50. PubMed ID: 18234451
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Salvage radical prostatectomy: refinement of an effective procedure.
    Pisters LL
    Semin Radiat Oncol; 2003 Apr; 13(2):166-74. PubMed ID: 12728446
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of postoperative prostate-specific antigen disease recurrence and the use of salvage therapy on the risk of death.
    Choueiri TK; Chen MH; D'Amico AV; Sun L; Nguyen PL; Hayes JH; Robertson CN; Walther PJ; Polascik TJ; Albala DM; Moul JW
    Cancer; 2010 Apr; 116(8):1887-92. PubMed ID: 20162710
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The management of high risk prostate cancer.
    Akduman B; Crawford ED
    J Urol; 2003 Jun; 169(6):1993-8. PubMed ID: 12771704
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A multi-institutional analysis comparing adjuvant and salvage radiation therapy for high-risk prostate cancer patients with undetectable PSA after prostatectomy.
    Budiharto T; Perneel C; Haustermans K; Junius S; Tombal B; Scalliet P; Renard L; Lerut E; Vekemans K; Joniau S; Van Poppel H
    Radiother Oncol; 2010 Dec; 97(3):474-9. PubMed ID: 20950879
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Radiation therapy after radical prostatectomy: impact on metastasis and survival.
    Boorjian SA; Karnes RJ; Crispen PL; Rangel LJ; Bergstralh EJ; Blute ML
    J Urol; 2009 Dec; 182(6):2708-14. PubMed ID: 19836762
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term outcome of patients with prostate cancer and pathologic seminal vesicle invasion (pT3b): effect of adjuvant radiotherapy.
    Lee HM; Solan MJ; Lupinacci P; Gomella LG; Valicenti RK
    Urology; 2004 Jul; 64(1):84-9. PubMed ID: 15245941
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Delayed/salvage radiation therapy in patients with elevated prostate specific antigen levels after radical prostatectomy. A long term follow-up.
    Medini E; Medini I; Reddy PK; Levitt SH
    Cancer; 1996 Sep; 78(6):1254-9. PubMed ID: 8826948
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Radiotherapy for high-risk patients after radical prostatectomy for prostate cancer: immediate postoperative or salvage?].
    Pasquier D; Kouto H; Ballereau C
    Prog Urol; 2009 Jul; 19(7):447-56. PubMed ID: 19559374
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neoadjuvant total androgen suppression and radiotherapy in the management of locally advanced prostate cancer.
    Roach M
    Semin Urol Oncol; 1996 May; 14(2 Suppl 2):32-7; discussion 38. PubMed ID: 8725889
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.